In-vivo effect of interleukin 3 and erythropoietin, either alone or in combination, on the hematopoietic toxicity associated with zidovudine

Cytokine

Volumn 5, Issue 1, 1993, Pages 62-71

  Gallicchio, Vincent S ^a,b   Hughes, Nedda K ^a,b   Tse, Kam Fai ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Erythropoietin; Hematopoiesis; Hematopoietic stem cells; Hematopoietic toxicity; Interleukin 3; Zidovudine

Indexed keywords

ERYTHROPOIETIN; INTERLEUKIN 3; ZIDOVUDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEUTROPENIA; NONHUMAN; ORAL DRUG ADMINISTRATION;

ANIMAL; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; FEMALE; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-3; MICE; MICE, INBRED C57BL; SUPPORT, U.S. GOV'T, NON-P.H.S.; ZIDOVUDINE;

ANIMALIA;

EID: 0027412376     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/1043-4666(93)90025-Z     Document Type: Article

References (22)

1. Yarchoan R, Klecker RW, Weinhold KJ, Markham PD, Lyerly HK, Durack DT, Galmann E, Nursinoff-Lehrman S, Blum RM, Barry DW, Shearer GM, Fischi MA, Mitsuya H, Gallo RC, Collins JM, Bolognesi DP, Myers S (1986) Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet i:575-577.
2. Fischi MA, Richman DD, Grieco MH, Gottlieb MS, Volverding PA, Laskin GL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, Jackson GG, Durack DT, King D (1987) The efficacy of 3'-azido-3'-deoxythymidine in the treatment of AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 317:185-191.
3. Fischi MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy D, Donin R, Powderly WA, Allen JD, Wong B, Mergian TC, McAuliffe VG, Hyslop NE, Rhame FS, Balfour HH, Spector SA, Volberding P, Petinelli C, Anderson J, The AIDS Clinical Trials Group (1990) The safety and efficacy of zidovudine (AZT) in the treatment of mildly symptomatic human immunodeficiency virus type I (HIV) infection: a double-blind placebo-controlled trial. Ann Intern Med 112:727-737.
4. Volberding PA, Lagakos SW, Koch MA, Pettinelli CA, Myers MW, Booth DK, Balfour HH, Reichman RC, Bartlett JA, Hirsch MS, Murphy RL, Hardy WD, Soeiro R, Fischl MA, Bartlett JG, Merigan TC, Hyslop NE, Richman DD, Valentine FT, Corey L (1990) Safety and efficacy of zidovudine in asymptomatic human immundeficiency virus infected individuals with less than 500 CD4+ cells/mm3. N Engl J Med 322:941-949.
5. Forester G (1987) Profound cytopenia secondary to azidothymidine. N Engl J Med 317:772.
6. Gill PS, Raick M, Brynes RH, Causey D, Loureiro C, Levine AM (1987) Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Ann IntMed 107:502-505.
7. Gottlieb MB, Wolfe PR, Chafey S (1987) Response of AIDS-related thrombocytopenia to intravenous and oral azidothymidine (3'-azido-3'-deoxythymidine). AIDS Res Hum Retroviruses 3:109-112.
8. Groopman JE, Mitsuyasu RT, deLeo MJ, Oette DH, Golde DW (1987) Effect of recombinant human granulocyte macrophage colony stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 317:593-598.
9. Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildran D, Hirsch MS, Jackson GG, Durach DT, Nusinoff-Lehrman S, AZT Collaborative Working Group (1987) The toxicity of azidothymidine (AZT) in the treatment of AIDS and AIDS-related complex: A double-blind, placebo-controlled trial. N Engl J Med 317:192-197.
10. Dournon E, Rogenbaum W. Michon C, Penonne C, DeTruchis P, Bouret E, Leevachen M, Matherson S, Gharakhanian S, Girard PM, Salmon D, Ceport C, Dazza MC, Regnier B (1988) Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet 2:1297-1300.
11. Sommadossi JP, Zhu Z, Carisle R (1987) Mechanism of toxicity of 3'-azido-3'-deoxythymidine in normal hematopoietic progenitor cells: evidence of inhibition of the de novo pyrimidine pathway. Proc Am Assoc Cancer Res 28:329A.
12. Dainiak N, Worthington M, Riordon MA, Kreckzo S, Goldman L (1988) 3'-azido-3'-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. BrJ Haematol 69:299-304.
13. Gallicchio VS, Doukas MA, Hulette BC, Hughes NK, Gass C (1989) Protection of 3'-Azido-3'-deoxythymidine induced toxicity to murine hematopoietic progenitors (CFU-GM, BFU-E, and CFU-Meg) with interleukin-1. Proc Soc Exp Biol Med 192:201-204.
14. Boglioio G, Lerza R, Mercibani M, Saviane A, Pannacciulli I (1989) Azidothymidine-induced depression of murine hemopoietic progenitor cells. Exp Hematol 16:938-940.
15. Cronkite EP, Bullis J (1990) In vivo toxicity of 3'-azido-3'-deoxythvmidine (AZT) on CBA/Ca mice. Int J Cell Cloning 8:332-345.
16. Gallicchio VS, Hughes NK, Hulette BC, Noblitt LN (1991) Effect of IL-1, IL-6, GM-CSF and erythropoietin on the in vitro toxicity associated with AZT on human bone marrow haematopoietic progenitor stem cells: CFU-GM and BFU-E. Antiviral Chem Chemother 2:76-85.
17. Gallicchio VS, Hughes NK (1992) Influence of interleukin-3 on zidovudine (AZT)-induced in vitro toxicity to human hematopoietic progenitors. Int J Cell Cloning 10:99-104.
18. Gallicchio VS, Hughes NK (1992) Suppression of murine hematopoiesis in vivo after chronic administration of zidovudine: evidence that zidovudine-induced anemia is the result of decreased bone marrow-derived, erythropoietin-responsive progenitor cells. Proc Soc Exp Biol Med 199:459-465.
19. Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE (1991) Granulocyte-macrophage colony stimulating factor mitigates the neutropenia of combined interferon-alpha and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi’s sarcoma. J Clin Oncol 9:802-808.
20. Kaplan LD, Kahn JO, Crowe S. Northfeet D, Neville P, Grossberg H, Abrams DI, Tracey J, Mills J, Volberding PA (1991) Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus - associated non-Hodgkin’s lymphoma: results of a randomized trial. J Clin Oncol 9:929-940.
21. Walker RE, Parker RI, Kovacs JA, Masur H, Lane HC, Carleton S, Kirk LE, Granick HR, Fauci AS (1988) Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. Ann Intern Med 108:372-376.
22. Fischl MA, Galpin JE, Levine JD, Groopman JE, Henry DH, Kennedy P, Miles S, Robbins W, Stanett B, Zalusky R, Abels RI, Tsai HC, Rusnick (1990) Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 322:1488-1493.